Charles E. Davidson Reports New 5.68% Stake in Nephros, Inc.

On September 16, 2026, Charles E. Davidson and CD Holding Company, LLC filed a Schedule 13G with the SEC, reporting a new 5.68% ownership stake in Nephros, Inc. (NEPH). The reporting persons disclosed beneficial ownership of 616,945 shares of common stock. According to the filing, the event triggering this requirement occurred on September 14, 2026. Charles E. Davidson serves as the Manager and President of CD Holding Company, LLC and may be deemed to beneficially own the shares held by the entity due to his controlling position. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The reporting persons share a principal business address in West Palm Beach, Florida, and have entered into a joint filing agreement. This initial 13G filing establishes Davidson as a significant shareholder in the New Jersey-based medical device company, which had approximately 10.86 million shares outstanding as of August 2026.